1. Home
  2. CDNL vs MGTX Comparison

CDNL vs MGTX Comparison

Compare CDNL & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardinal Infrastructure Group Inc. Class A Common Stock

CDNL

Cardinal Infrastructure Group Inc. Class A Common Stock

N/A

Current Price

$15.29

Market Cap

888.6M

Sector

N/A

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$9.49

Market Cap

881.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNL
MGTX
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
888.6M
881.7M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
CDNL
MGTX
Price
$15.29
$9.49
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
★ $47.25
$27.75
AVG Volume (30 Days)
★ 1.2M
642.3K
Earning Date
11-12-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.02
EPS
0.53
★ 1.30
Revenue
★ $456,045,369.00
$81,391,000.00
Revenue This Year
$95.00
$314.19
Revenue Next Year
$24.54
N/A
P/E Ratio
$27.04
★ $6.91
Revenue Growth
44.69
★ 144.57
52 Week Low
$12.51
$6.62
52 Week High
$96.40
$15.35

Technical Indicators

Market Signals
Indicator
CDNL
MGTX
Relative Strength Index (RSI) 37.79 44.07
Support Level $13.05 $8.88
Resistance Level $27.68 $10.11
Average True Range (ATR) 1.21 0.50
MACD 0.68 0.06
Stochastic Oscillator 71.60 54.75

Price Performance

Historical Comparison
CDNL
MGTX

About CDNL Cardinal Infrastructure Group Inc. Class A Common Stock

Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. The company provides wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. It derives all revenue in the United States of America from construction projects based in North Carolina and South Carolina.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: